Liraglutide 3-PAK 18 MG/3 ML 3ML
Ended Awarded
- Contract number
- SPE2DB26FS2PB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,514
Award facts
- Contract value 100% obligated
- $2,514.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Liraglutide 3-Pak 18 mg/3 mL (a diabetes medication) with a ceiling value of $2,514.32 and an ultimate completion date of November 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. The company's comprehensive SPE2DX prime contract vehicle supports global pharmaceutical supply needs across the Defense Health Agency and other government healthcare systems, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order represents one of numerous pharmaceutical procurement transactions fulfilled by AmerisourceBergen under its federal contract portfolio, demonstrating the company's capability to meet urgent medical supply requirements through the DLA's Medical Supply Chain network.
Quick answers
Who was awarded contract SPE2DB26FS2PB?
SPE2DB26FS2PB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FS2PB worth?
The government has obligated $2,514 on SPE2DB26FS2PB.
Is contract SPE2DB26FS2PB an order under another contract?
Yes. SPE2DB26FS2PB is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB26FS2PB competed?
The extent of competition for SPE2DB26FS2PB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award